![]() |
|
|
Vol. 288, Issue 2, 805-813, February 1999
, F. U.
Müller,
Institut für Pharmakologie und Toxikologie,
Westfälische Wilhelms-Universität Münster, Germany
Diadenosine tetraphosphate (AP4A) is an endogenous compound
and exerts diverse physiological effects in animal systems. However, the effects of AP4A on inotropy in ventricular cardiac
preparations have not yet been studied. The effects of AP4A
on force of contraction (FOC) were studied in isolated electrically
driven guinea pig and human cardiac preparations. Furthermore, the
effects of AP4A on L-type calcium current and
[Ca]i were studied in isolated guinea pig ventricular
myocytes. In guinea pig left atria, AP4A (0.1-100 µM)
reduced FOC maximally by 36.5 ± 4.3%. In guinea pig papillary muscles, AP4A (100 µM) alone was ineffective, but
reduced isoproterenol-stimulated FOC maximally by 29.3 ± 3.4%.
The negative inotropic effects of AP4A in atria and
papillary muscles were abolished by the A1-adenosine receptor antagonist 1,3-dipropyl-cyclopentylxanthine. In guinea pig ventricular myocytes, AP4A (100 µM) attenuated
isoproterenol-stimulated L-type calcium current and
[Ca]i. In human atrial and ventricular preparations,
AP4A (100 µM) alone increased FOC to 158.3 ± 12.4% and 167.5 ± 25.1%, respectively. These positive inotropic
effects were abolished by the P2-purinoceptor
antagonist suramin. On the other hand, AP4A (100 µM) reduced FOC by 27.2 ± 7.4% in isoproterenol-stimulated human ventricular trabeculae. The latter effect was abolished by
1,3-dipropyl-cyclopentylxanthine. In summary, after beta
adrenergic stimulation AP4A exerts negative inotropic
effects in animal and human ventricular preparations via stimulation of
A1-adenosine receptors. In contrast, AP4A alone
can exert positive inotropic effects via P2-purinoceptors
in human ventricular myocardium. Thus, P2-purinoceptor
stimulation might be a new positive inotropic principle in the human myocardium.
This article has been cited by other articles:
![]() |
A. L. Garcia-Villalon, L. Monge, N. Fernandez, A. Salcedo, R. Narvaez-Sanchez, and G. Dieguez Coronary response to diadenosine pentaphosphate after ischaemia-reperfusion in the isolated rat heart Cardiovasc Res, February 1, 2009; 81(2): 336 - 343. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Gergs, P. Boknik, W. Schmitz, A. Simm, R.-E. Silber, and J. Neumann A positive inotropic effect of ATP in the human cardiac atrium Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1716 - H1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Luo, V. Jankowski, N. Gungar, J. Neumann, W. Schmitz, W. Zidek, H. Schluter, and J. Jankowski Endogenous Diadenosine Tetraphosphate, Diadenosine Pentaphosphate, and Diadenosine Hexaphosphate in Human Myocardial Tissue Hypertension, May 1, 2004; 43(5): 1055 - 1059. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vassort Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium Physiol Rev, April 1, 2001; 81(2): 767 - 806. [Abstract] [Full Text] [PDF] |
||||